Success Metrics

Clinical Success Rate

83.3%

Based on 5 completed trials

Completion Rate

83%(5/6)

Active Trials

2(12%)

Results Posted

0%(0 trials)

Terminated

1(6%)

Phase Distribution

Ph not_applicable

65%

Ph phase_3

12%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution13 total trials

Phase 3Large-scale testing

2(15.4%)

N/ANon-phased studies

11(84.6%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(4)

Completed(5)

Terminated(2)

Other(6)

Detailed Status

unknown6

Completed5

Not yet recruiting2

Recruiting2

Withdrawn1

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

83.3%

Most Advanced

Phase 3

Trials by Phase

Phase 32 (15.4%)

N/A11 (84.6%)

Trials by Status

completed529%

not_yet_recruiting212%

withdrawn16%

recruiting212%

terminated16%

unknown635%

Recent Activity

2 active trials

Showing 5 of 17

not_yet_recruiting

Long-term Efficacy and Safety of LSD Versus TIPS for Cirrhotic Portal Hypertension Bleeding and Hypersplenism

NCT07490405

recruitingnot_applicable

Embolization of Large Spontaneous Portosystemic Shunts for the Prevention of Post-TIPS Hepatic Encephalopathy

NCT02156232

View all 17 trials

Clinical Trials (17)

Showing 17 of 17 trials

NCT07490405

Long-term Efficacy and Safety of LSD Versus TIPS for Cirrhotic Portal Hypertension Bleeding and Hypersplenism

Not Yet Recruiting

NCT05346393Not Applicable

HRS-AKI Treatment With TIPS in Patients With Cirrhosis

Recruiting

NCT05596253

Incidence and Predictors of Post-TIPS Heart Failure in Patients With Cirrhosis

Recruiting

NCT06319131Not Applicable

Nadroparin Versus TIPS in Cirrhotic Patients With Refractory Asymptomatic PVT

Not Yet Recruiting

NCT02156232Not Applicable

Embolization of Large Spontaneous Portosystemic Shunts for the Prevention of Post-TIPS Hepatic Encephalopathy

Completed

NCT02119988Not Applicable

TIPS Combined With Variceal Embolization for the Prevention of Variceal Rebleeding in Patients With Cirrhosis

Completed

NCT03172273Not Applicable

Early Use of TIPS With Polytetrafluoroethylene(PTFE) Covered Stents in Cirrhotic Patients With Refractory Ascites

Unknown

NCT05141617Not Applicable

Management of Oxaliplatin-related Gastroesophageal Variceal Bleeding

Unknown

NCT05037643Not Applicable

Pre-emptive Transjugular Intrahepatic Portosystemic Shunt (TIPS) in Cystic Fibrosis Related Liver Disease

Completed

NCT04387058Not Applicable

Incidence of Diabetes and Metabolic Disorders After TIPS in Cirrhotic Patients

Unknown

NCT04198259Not Applicable

Interventional Devascularization Plus HVPG-Guided Carvedilol Therapy vs TIPS

Unknown

NCT02612519Not Applicable

Alfapump System Versus Transjugular Intrahepatic Portosystemic Shunt and Paracentesis in the Treatment of Ascites

Terminated

NCT03933891

Magnetic Resonance Technics for the Assessment of Liver Function Before and After TIPS

Unknown

NCT03083925

Viatorr CX Case-control Study for Complications of Portal Hypertension

Completed

NCT03422419Phase 3

TIPS or Anticoagulation in Portal Vein Thrombosis

Withdrawn

NCT02853526Phase 3

TIPS for Variceal Rebleeding in Cirrhotic Patients With Occlusive Portal Vein Thrombosis and CTPV

Unknown

NCT00222014Not Applicable

TIPS With Coated Stents for Refractory Ascites in Patients With Cirrhosis

Completed

All 17 trials loaded

Drug Details

Intervention Type: PROCEDURE
Total Trials: 17